MDWD Projected Dividend Yield
Ord (New)/Mediwound Ltd. ( NASDAQ : MDWD )Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures, and commercializes cost-effective bio-therapeutic solutions for tissue repair and regeneration. Its portfolio includes next-generation protein-based therapies for burn and wound care, such as NexoBrid, a topical product that removes eschar without harming healthy tissue; EscharEx, a drug candidate for chronic and hard-to-heal wounds; and MW005, a topical treatment for non-melanoma skin cancers, all based on proteolytic enzymes enriched in bromelain. 21 YEAR PERFORMANCE RESULTS |
MDWD Dividend History Detail MDWD Dividend News MDWD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |